The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

Unlocking the Value of Personalised Cancer Care

Unlocking the Value of Personalised Cancer Care

Access to Personalised Oncology in Europe, a new report by LSE consulting commissioned by EFPIA, identifies the barriers to better deployment of personalised cancer treatment for European cancer patients and makes concrete recommendations on how to advance and...
Oncology Meeting: EORTC – IBCD 2020 (23 October 2020)

Oncology Meeting: EORTC – IBCD 2020 (23 October 2020)

IBCD 2020 will explore routes through the continually evolving scientific, methodological and regulatory environment for drug and biomarker development. The EORTC, NCI, EMA, and AACR will will work alongside FDA and PMDA specialists  to build upon recommendations and...

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752

info@cddf.org
Tel: +32 2 880 62 70